The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, among others, is a subunit COVID-19 vaccine developed by Novavax and the...
74 KB (5,621 words) - 06:11, 21 October 2024
February 2022, as the fifth vaccine against COVID-19, following Pfizer/BioNTech, Moderna, Janssen and AstraZeneca. In June 2013, Novavax acquired the Matrix-M...
31 KB (2,866 words) - 14:32, 20 November 2024
authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines. Ten vaccines have been approved for emergency or full use by at least one...
322 KB (19,558 words) - 03:33, 16 September 2024
A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus...
205 KB (23,333 words) - 06:21, 21 November 2024
Sanofi–GSK COVID-19 vaccine sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK. The Sanofi–GSK COVID‑19 vaccine...
19 KB (1,436 words) - 08:53, 24 September 2024
Vaxart COVID-19 vaccine is a COVID-19 vaccine candidate developed by Vaxart. "Patent Landscape Report COVID-19-related vaccines and therapeutics" (PDF)...
2 KB (108 words) - 10:50, 24 September 2024
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company...
260 KB (22,097 words) - 23:43, 14 October 2024
variety of unfounded conspiracy theories and other misinformation about COVID-19 vaccines have spread based on misunderstood or misrepresented science, religion...
132 KB (12,911 words) - 03:13, 18 November 2024
the Health Ministry concluded a purchase agreement with Novavax for its non-mRNA COVID-19 vaccine, with shipments expected to arrive in Singapore before...
39 KB (2,991 words) - 10:55, 3 November 2024
Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for the prevention of COVID-19. It was...
214 KB (17,080 words) - 15:51, 27 September 2024
NVX-CoV2373, a COVID‑19 vaccine being developed by Novavax CZ AS (a subsidiary of Novavax, Inc.) and a rolling review of CVnCoV, a COVID‑19 vaccine being developed...
122 KB (11,033 words) - 06:12, 17 November 2024
The Janssen COVID‑19 vaccine, (Ad26.COV2.S) sold under the brand name Jcovden, is a COVID‑19 vaccine that was developed by Janssen Vaccines in Leiden,...
141 KB (11,331 words) - 06:12, 24 September 2024
COVID-19 vaccine clinical research uses clinical research to establish the characteristics of COVID-19 vaccines. These characteristics include efficacy...
98 KB (19,258 words) - 11:27, 22 November 2024
Gam-COVID-Vac (Russian: Гам-КОВИД-Вак, the name under which it is legally registered and produced) is an adenovirus viral vector vaccine for COVID-19 developed...
154 KB (13,917 words) - 19:29, 18 November 2024
Moderna, Sinopharm BIBP, Sputnik Light and Novavax. As of February 19, 2023, 166,423,405 total vaccine doses have been administered throughout the country...
128 KB (9,955 words) - 00:32, 16 August 2024
Stemirna COVID-19 vaccine is a COVID-19 vaccine candidate developed by Stemirna Therapeutics. "Patent Landscape Report COVID-19-related vaccines and therapeutics"...
3 KB (113 words) - 09:01, 24 September 2024
COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two whole inactivated virus COVID-19 vaccines developed...
90 KB (8,588 words) - 08:11, 24 September 2024
(ARTG). As of 14 June 2021, Novavax had entered the final stage of trials. As of 8 July 2021, the Novavax COVID-19 vaccine was under evaluation by the...
177 KB (12,115 words) - 21:09, 21 November 2024
CoviVac (Russian: КовиВак) is an inactivated virus-based COVID-19 vaccine developed by the Chumakov Centre [ru], which is an institute of the Russian Academy...
8 KB (576 words) - 14:52, 20 October 2024
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National...
177 KB (13,698 words) - 16:52, 23 October 2024
the Novavax COVID-19 vaccine for people aged 18 and above. The first doses are expected to arrive in the country in March 2022. New Zealand COVID-19 Response...
7 KB (495 words) - 06:49, 20 November 2024
Medical Sciences COVID-19 vaccine, or IMBCAMS COVID-19 vaccine, traded as Covidful (Chinese: 科维福; pinyin: Kēwéifú), is a COVID-19 vaccine developed by Institute...
4 KB (192 words) - 08:25, 24 September 2024
Inovio COVID-19 vaccine is a COVID-19 vaccine candidate developed by Inovio Pharmaceuticals. In February 2020 after receiving details of the genetic sequence...
9 KB (880 words) - 06:15, 24 September 2024
53 billion COVID-19 vaccine doses have been administered worldwide, with 70.6 percent of the global population having received at least one dose. While 4.19 million...
156 KB (13,918 words) - 21:34, 29 September 2024
The Sanofi–Translate Bio COVID-19 vaccine, also known as MRT5500 or VAW00001, was a COVID-19 vaccine candidate developed by Sanofi Pasteur and Translate...
5 KB (294 words) - 08:54, 24 September 2024
MVC-COV1901 and also known as the Medigen COVID-19 vaccine, is a protein subunit COVID-19 vaccine developed by Medigen Vaccine Biologics Corporation in Taiwan,...
15 KB (1,455 words) - 06:02, 24 September 2024
Operation Warp Speed (redirect from Trump vaccine)
Retrieved July 7, 2020. "HHS, DOD Collaborate with Novavax to Produce Millions of COVID-19 Investigational Vaccine Doses in Commercial-Scale Manufacturing Demonstration...
71 KB (5,872 words) - 05:25, 14 November 2024
the COVID-19 vaccine. COVID-19 vaccine hesitancy in the United States can be considered as part of the broader history of vaccine hesitancy. Vaccine hesitancy...
40 KB (3,771 words) - 01:07, 31 August 2024
West China Hospital COVID-19 vaccine is a COVID-19 vaccine candidate developed by West China Hospital. In August 2020, WestVac Biopharma started phase...
4 KB (289 words) - 01:19, 13 September 2024
most COVID‑19 vaccines were two-dose vaccines, with the exception single-dose vaccines Convidecia and the Janssen COVID‑19 vaccine, and vaccines with three-dose...
288 KB (33,185 words) - 16:52, 20 November 2024